SGLT2 inhibitors
4 stories
-
healthSGLT2 Inhibitors Cut Heart Transplant Rejection Risk in Diabetics
Meta-analysis finds SGLT2 inhibitors reduce rejection in heart transplant patients with diabetes, though mortality and other outcomes unchanged.
-
healthImmune Cells Retain 'Memory' of Obesity for Years After Weight Loss
New research reveals immune cells carry a lasting 'memory' of obesity, potentially raising disease risk for up to a decade after weight loss.
-
healthNew Study Reveals Safer Diabetes Drugs for Seniors
Real-world data identifies safer antihyperglycemic agents for older adults with type 2 diabetes, reducing risks of hypoglycemia and other serious complications.
-
healthNephrology Expert Patrick Mark on the Rising Threat of Kidney Disease
Professor Patrick Mark discusses the complex link between kidney disease and cardiovascular health, new treatment frontiers, and the critical need for proactive policy.